3,026
Views
9
CrossRef citations to date
0
Altmetric
Study Design Articles

Strengthening the delivery of asthma and chronic obstructive pulmonary disease care at primary health-care facilities: study design of a cluster randomized controlled trial in Pakistan

, , &
Article: 28225 | Received 14 Apr 2015, Accepted 09 Sep 2015, Published online: 16 Nov 2015

References

  • Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014; 11(3): 404–6.
  • World Health Organization. Burden of COPD. 2015. Available from: http://www.who.int/respiratory/copd/burden/en/ [cited 8 May 2015]..
  • Marks G, Pearce N, Strachan D, Asher I. Global burden of disease due to asthma. 2014. Available from: http://www.globalasthmareport.org/burden/burden.php [cited 8 May 2015]..
  • World Health Organization. 2015; Scope: asthma. Available from: http://www.who.int/respiratory/asthma/scope/en/ [cited 8 May 2015]..
  • The World Bank. 2015; Data: Pakistan. Available from: http://data.worldbank.org/country/pakistan [cited 8 May 2015]..
  • Mendis S, Armstrong T, Bettcher D, Branca F, Lauer J, Mace C, etal. Global status report on noncommunicable diseases 2014. Report No.: ISBN 978 92 4 156485 4, Contract No.: Document Number. 2014; Geneva: World Health Organization.
  • Tageldin MA, Nafti S, Khan JA, Nejjari C, Beji M, Mahboub B, etal. Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012; 106: S25–32.
  • Ahmad K, Jafary F, Jehan I, Hatcher J, Khan AQ, Chaturvedi N, etal. Prevalence and predictors of smoking in Pakistan: results of the National Health Survey of Pakistan. Eur J Cardiovasc Prev Rehabil. 2005; 12(3): 203–8. [PubMed Abstract].
  • Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004; 59(5): 469–78.
  • The International Union against Tuberculosis and Lung Disease. The global asthma report 2011. 2011; Paris, France: The International Union against Tuberculosis and Lung Disease.
  • Nishtar S. The national action plan for the prevention and control of non-communicable diseases and health promotion in Pakistan – Prelude and finale. J Pak Med Assoc. 2004; 54(12 Suppl 3): S1. [PubMed Abstract].
  • Nishtar S, Bile KM, Ahmed A, Faruqui AMA, Mirza Z, Shera S, etal. Peer reviewed: process, rationale, and interventions of Pakistan's national action plan on chronic diseases. Prev Chronic Dis. 2006; 3(1): A14. [PubMed Abstract] [PubMed CentralFull Text].
  • GARD action plan 2008–2013. 2008. Available from: http://www.who.int/gard/publications/action_plan/en/ [cited 19 May 2015]..
  • Manzar N, Haque AS, Manzar B, Irfan M. The efficacy of spirometry as a screening tool in detection of air flow obstruction. Oper Repir Med J. 2010; 4: 71–5.
  • Mahmud T, Bokhari SN, Aasim M. Comparison of frequency of undiagnosed chronic obstructive pulmonary disease in current or former tobacco smokers having ischaemic heart disease. Indian J Chest Dis Allied Sci. 2012; 54(2): 111–16. [PubMed Abstract].
  • Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, etal. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007; 85(4): 279–88.
  • Yusuf MO. Systems for the management of respiratory disease in primary care – an international series: Pakistan. Prim Care Respir J. 2009; 18(1): 3–9.
  • World Health Organization. Stop tuberculosis. 2015. Available from: http://www.emro.who.int/pak/programmes/stop-tuberculosis.html [cited 19 August 2015]..
  • Vestbo J, Hurd SS, Agust AG, Jones PW, Vogelmeier C, Anzueto A, etal. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187(4): 347–65. [PubMed Abstract].
  • Boulet L-P, FitzGerald JM, Levy ML, Cruz AA, Pedersen S, Haahtela T, etal. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J. 2012; 39(5): 1220–9.
  • O'Reilly J, Jones MM, Parnham J, Lovibond K, Rudolf M. Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. BMJ. 2010; 340: c3134.
  • British Thoracic Society SIGN. British guideline on the management of asthma. Thorax. 2008; 63(Suppl 4): 1–121.
  • WHO. Implementation tools: package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings. 2013; Geneva: WHO.
  • Arsalan A, Shad Z, Sabah A, Ahmed FR, Malik A, Shakeel O. Prevalence and therapy of chronic obstructive disease in Karachi. Pak J Med Dentistry. 2013; 2(4): 26–32.
  • Cowie RL, Conley DP, Underwood MF, Reader PG. A randomised controlled trial of the Buteyko technique as an adjunct to conventional management of asthma. Respir Med. 2008; 102(5): 726–32.
  • Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, etal. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010; 126(5): 926–38.
  • Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005; 128(6): 3810–16.
  • Marin JM, Cote CG, Diaz O, Lisboa C, Casanova C, Lopez MV, etal. Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med. 2011; 105(6): 916–21.
  • Smith CJ, Gribbin J, Challen KB, Hubbard RB. The impact of the 2004 NICE guideline and 2003 General Medical Services contract on COPD in primary care in the UK. QJM. 2004; 101(2): 145–53.
  • Pont LG, van der Molen T, Denig P, van der Werf GT, Haaijer-Ruskamp FM. Relationship between guideline treatment and health-related quality of life in asthma. Eur Respir J. 2004; 23(5): 718–22.
  • Hilberink SR, Jacobs JE, Bottema BJ, de Vries H, Grol RP. Smoking cessation in patients with COPD in daily general practice (SMOCC): six months’ results. Prev Med. 2005; 41(5–6): 822–7.